1. Home
  2. CASI vs INDO Comparison

CASI vs INDO Comparison

Compare CASI & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • INDO
  • Stock Information
  • Founded
  • CASI 1991
  • INDO 2018
  • Country
  • CASI China
  • INDO Indonesia
  • Employees
  • CASI N/A
  • INDO N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • INDO Oil & Gas Production
  • Sector
  • CASI Health Care
  • INDO Energy
  • Exchange
  • CASI Nasdaq
  • INDO Nasdaq
  • Market Cap
  • CASI 35.8M
  • INDO 41.5M
  • IPO Year
  • CASI 1996
  • INDO 2019
  • Fundamental
  • Price
  • CASI $2.28
  • INDO $2.92
  • Analyst Decision
  • CASI Strong Buy
  • INDO
  • Analyst Count
  • CASI 1
  • INDO 0
  • Target Price
  • CASI $4.00
  • INDO N/A
  • AVG Volume (30 Days)
  • CASI 384.8K
  • INDO 336.3K
  • Earning Date
  • CASI 11-13-2025
  • INDO 10-24-2025
  • Dividend Yield
  • CASI N/A
  • INDO N/A
  • EPS Growth
  • CASI N/A
  • INDO N/A
  • EPS
  • CASI N/A
  • INDO N/A
  • Revenue
  • CASI $31,564,000.00
  • INDO $2,667,508.00
  • Revenue This Year
  • CASI N/A
  • INDO N/A
  • Revenue Next Year
  • CASI N/A
  • INDO N/A
  • P/E Ratio
  • CASI N/A
  • INDO N/A
  • Revenue Growth
  • CASI 36.64
  • INDO N/A
  • 52 Week Low
  • CASI $1.09
  • INDO $2.10
  • 52 Week High
  • CASI $7.55
  • INDO $7.95
  • Technical
  • Relative Strength Index (RSI)
  • CASI 55.66
  • INDO 50.78
  • Support Level
  • CASI $2.18
  • INDO $2.83
  • Resistance Level
  • CASI $2.49
  • INDO $3.10
  • Average True Range (ATR)
  • CASI 0.19
  • INDO 0.13
  • MACD
  • CASI -0.03
  • INDO 0.01
  • Stochastic Oscillator
  • CASI 33.33
  • INDO 32.35

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About INDO Indonesia Energy Corporation Limited

Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.

Share on Social Networks: